BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11955285)

  • 1. Localization and function of a calmodulin-apocalmodulin-binding domain in the N-terminal part of the type 1 inositol 1,4,5-trisphosphate receptor.
    Sienaert I; Nadif Kasri N; Vanlingen S; Parys JB; Callewaert G; Missiaen L; de Smedt H
    Biochem J; 2002 Jul; 365(Pt 1):269-77. PubMed ID: 11955285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal Ca2+-independent calmodulin-binding site on the inositol 1,4,5-trisphosphate receptor is responsible for calmodulin inhibition, even though this inhibition requires Ca2+.
    Kasri NN; Bultynck G; Smyth J; Szlufcik K; Parys JB; Callewaert G; Missiaen L; Fissore RA; Mikoshiba K; de Smedt H
    Mol Pharmacol; 2004 Aug; 66(2):276-84. PubMed ID: 15266018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A calmodulin antagonist reveals a calmodulin-independent interdomain interaction essential for activation of inositol 1,4,5-trisphosphate receptors.
    Sun Y; Taylor CW
    Biochem J; 2008 Dec; 416(2):243-53. PubMed ID: 18637794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction.
    Bultynck G; Szlufcik K; Kasri NN; Assefa Z; Callewaert G; Missiaen L; Parys JB; De Smedt H
    Biochem J; 2004 Jul; 381(Pt 1):87-96. PubMed ID: 15015936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ and calmodulin differentially modulate myo-inositol 1,4, 5-trisphosphate (IP3)-binding to the recombinant ligand-binding domains of the various IP3 receptor isoforms.
    Vanlingen S; Sipma H; De Smet P; Callewaert G; Missiaen L; De Smedt H; Parys JB
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):275-80. PubMed ID: 10677344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human ether à go-go potassium channels by Ca2+/calmodulin binding to the cytosolic N- and C-termini.
    Ziechner U; Schönherr R; Born AK; Gavrilova-Ruch O; Glaser RW; Malesevic M; Küllertz G; Heinemann SH
    FEBS J; 2006 Mar; 273(5):1074-86. PubMed ID: 16478480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of inositol 1,4,5-trisphosphate binding to the recombinant ligand-binding site of the type-1 inositol 1,4, 5-trisphosphate receptor by Ca2+ and calmodulin.
    Sipma H; De Smet P; Sienaert I; Vanlingen S; Missiaen L; Parys JB; De Smedt H
    J Biol Chem; 1999 Apr; 274(17):12157-62. PubMed ID: 10207043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium regulation of inositol 1,4,5-trisphosphate receptors.
    Joseph SK; Brownell S; Khan MT
    Cell Calcium; 2005 Dec; 38(6):539-46. PubMed ID: 16198415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode.
    Ye Q; Li X; Wong A; Wei Q; Jia Z
    Biochemistry; 2006 Jan; 45(3):738-45. PubMed ID: 16411749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troponin C/calmodulin chimeras as erythrocyte plasma membrane Ca2+-ATPase activators.
    Fidalgo da Silva E; Freire MM; Barrabin H; Sorenson MM; Tikunova S; Johnson JD; Chandra M; Pearlstone JR; Scofano HM
    Int J Biochem Cell Biol; 2006 Feb; 38(2):209-21. PubMed ID: 16213185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPC channel interactions with calmodulin and IP3 receptors.
    Zhu MX; Tang J
    Novartis Found Symp; 2004; 258():44-58; discussion 58-62, 98-102, 263-6. PubMed ID: 15104175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IP3 receptor/Ca2+ channel and its cellular function.
    Mikoshiba K
    Biochem Soc Symp; 2007; (74):9-22. PubMed ID: 17233576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of a trapped intermediate of calmodulin: calcium regulation of EF-hand proteins from a new perspective.
    Grabarek Z
    J Mol Biol; 2005 Mar; 346(5):1351-66. PubMed ID: 15713486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding of calmodulin domains to constitutive and inducible nitric oxide synthase enzymes.
    Spratt DE; Taiakina V; Palmer M; Guillemette JG
    Biochemistry; 2007 Jul; 46(28):8288-300. PubMed ID: 17580957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the RYR1 and RYR2 Ca2+ release channel isoforms by Ca2+-insensitive mutants of calmodulin.
    Fruen BR; Black DJ; Bloomquist RA; Bardy JM; Johnson JD; Louis CF; Balog EM
    Biochemistry; 2003 Mar; 42(9):2740-7. PubMed ID: 12614169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calmodulin-binding domain in the mouse type 1 inositol 1,4,5-trisphosphate receptor.
    Yamada M; Miyawaki A; Saito K; Nakajima T; Yamamoto-Hino M; Ryo Y; Furuichi T; Mikoshiba K
    Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):83-8. PubMed ID: 7755592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apocalmodulin and Ca2+ calmodulin bind to the same region on the skeletal muscle Ca2+ release channel.
    Moore CP; Rodney G; Zhang JZ; Santacruz-Toloza L; Strasburg G; Hamilton SL
    Biochemistry; 1999 Jun; 38(26):8532-7. PubMed ID: 10387100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpastatin binds to a calmodulin-binding site of cardiac Cav1.2 Ca2+ channels.
    Saud ZA; Minobe E; Wang WY; Han DY; Horiuchi M; Hao LY; Kameyama M
    Biochem Biophys Res Commun; 2007 Dec; 364(2):372-7. PubMed ID: 17950697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two IQ-motifs and Ca2+/calmodulin regulate the rat myosin 1d ATPase activity.
    Köhler D; Struchholz S; Bähler M
    FEBS J; 2005 May; 272(9):2189-97. PubMed ID: 15853803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic and biochemical studies of calcium- and phosphorylation-dependent calmodulin complexes in Mammalian cells.
    Jang DJ; Guo M; Wang D
    J Proteome Res; 2007 Sep; 6(9):3718-28. PubMed ID: 17696464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.